Steady turnover of amyloid fibril proteins in gastric mucosa after liver transplantation in familial amyloid polyneuropathy

References

• Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 2002;58:1001–7
   PubMed Web of Science ®Google Scholar
• Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid 2003;10:160–84
   PubMed Web of Science ®Google Scholar
• Holmgren G, Steen L, Ekstedt J, Groth CG, Ericzon BG, Eriksson S, Andersen O, et al. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP me30). Clin Genet 1991;40:242–6
   PubMed Web of Science ®Google Scholar
• Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RH. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 1997;64:74–80
   PubMed Web of Science ®Google Scholar
• Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, O’Grady J, et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 1998;66:229–33
   PubMed Web of Science ®Google Scholar
• Yazaki M, Tokuda T, Nakamura A, Higashikata T, Koyama J, Higuchi K, Harihara Y, et al. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin. Biochem Biophys Res Commun 2000;274:702–6
   PubMed Web of Science ®Google Scholar
• Yazaki M, Mitsuhashi S, Tokuda T, Kametani F, Takei Y, Koyama J, Kawamorita A, et al. Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients. Am J Transplant 2007;7:235–4
   PubMed Web of Science ®Google Scholar
• Olofsson BO, Backman C, Karp K, Suhr OB. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 2002;73:745–51
   PubMed Web of Science ®Google Scholar
• Liepnieks JJ, Benson MD. Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation. Amyloid 2007;14:277–82
   PubMed Web of Science ®Google Scholar
• Tsuchiya A, Yazaki M, Kametani F, Takei Y, Ikeda S. Marked regression of abdominal fat amyloid in patients with familial amyloid polyneuropathy during long-term follow-up after liver transplantation. Liver Transpl 2008;14:563–70
   PubMed Web of Science ®Google Scholar
• Ikeda S, Nakano T, Yanagisawa N, Nakazato M, Tsukagoshi H. Asymptomatic homozygous gene carrier in a family with type I familial amyloid polyneuropathy. Eur Neurol 1992;32:308–13
   PubMed Web of Science ®Google Scholar
• Takei Y, Ikeda S, Hashikura Y, Ikegami T, Kawasaki S. Partial liver transplantation from living donors in familial amyloid polyneuropathy: a follow-up study of the first 11 patients. Ann Intern Med 1999;131:592–5
   PubMed Web of Science ®Google Scholar
• Tojo K, Sekijima Y, Kelly JW, Ikeda S. Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis. Neurosci Res 2006;56:441–9
   PubMed Web of Science ®Google Scholar
• Hazenberg BP, Limburg PC, Bijzet J, van Rijswijk MH. A quantitative method for detecting deposits of amyloid A protein in aspirated fat tissue of patients with arthritis. Ann Rheum Dis 1999;58:96–102
   PubMed Web of Science ®Google Scholar
• Glenner GG. Amyloid deposits and amyloidosis: the β-fibrilloses. N Engl J Med 1980;302:1283–92
   PubMed Web of Science ®Google Scholar
• Gillmore JD, Hawkins PN. Amyloidosis and the respiratory tract. Thorax 1999;54:444–51
   PubMed Web of Science ®Google Scholar
• Kuroda T, Wada Y, Kobayashi D, Murakami S, Sakai T, Hirose S, Tanabe N, et al. Effective anti-TNF alpha therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis. J Rheumatol 2009;36:2409–15
   PubMed Web of Science ®Google Scholar
• Katoh N, Matsuda M, Tsuchiya-Suzuki A, Ikeda S. Regression of gastroduodenal amyloid deposition in systemic AL amyloidosis after intensive chemotherapies. Br J Haematol 2011;153:535–8
   PubMed Web of Science ®Google Scholar
• Liepnieks JJ, Zhang LQ, Benson MD. Progression of transthyretin amyloid neuropathy after liver transplantation. Neurology 2010;75:324–7
   PubMed Web of Science ®Google Scholar
• Obayashi K, Ueda M, Oshima T, Kawahara S, Misumi Y, Yamashita T, Jono H, et al. Pathological changes long after liver transplanataion in a familial amyloidotic polyneuropathy patient. BMJ Case Reports 2012, epub ahead of print. DOI:10.1136/bcr-2012-006593
   PubMedGoogle Scholar
• Sakashita N, Ando Y, Haraoka K, Terazaki H, Yamashita T, Nakamura M, Takeya M. Severe congestive heart failure with cardiac liver cirrhosois 10 years after orthotopic liver transplantation for familial amyloidotic polyneuropathy. Pathol Int 2006;56:408–12
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Wiseman RL, Matteson J, Hammarström P, Miller SR, Sawkar AR, Balch WE, et al. The biological and chemical basis for tissue-selective amyloid disease. Cell 2005;121:73–85
   PubMed Web of Science ®Google Scholar
• Bergström J, Gustavsson A, Hellman U, Sletten K, Murphy CL, Weiss DT, Solomon A, et al. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. J Pathol 2005;206:224–32
   PubMed Web of Science ®Google Scholar
• Ihse E, Suhr OB, Hellman U, Westermark P. Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis. J Mol Med 2011;89:171–80
   PubMed Web of Science ®Google Scholar
• Gustafsson S, Ihse E, Henein MY, Westermark P, Lindqvist P, Suhr OB. Amyloid fibril composition as a predictor of development of cardiomyopathy after liver transplantation for hereditary transthyretin amyloidosis. Transplantation 2012;93:1017–23
   PubMed Web of Science ®Google Scholar
• Westermark P, Sletten K, Johansson B, Cornwell GG 3rd. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990;87:2843–5
   PubMed Web of Science ®Google Scholar
• Kodaira M, Sekijima Y, Tojo K, Tsuchiya A, Yazaki M, Ikeda S, Sekijima Y, et al. Non-senile wild-type transthyretin systemic amyloidosis presenting as bilateral carpal tunnel syndrome. J Peripher Nerv Syst 2008; 13:148–50
   PubMed Web of Science ®Google Scholar
• Tsuchiya-Suzuki A, Yazaki M, Kametani F, Sekijima Y, Ikeda S. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met. Hum Pathol 2011;42:236–43
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Kelly JW, Ikeda S. Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidosis. Curr Pharm Des 2008;14:3219–30
   PubMed Web of Science ®Google Scholar